Membrane/Core Nanoparticles for Delivery of Therapeutic Nucleic Acid - Nanotechnology for the Delivery of Therapeutic Nucleic Acids - page 91

overexpression under K-selection after MYC and HRAS oncogene
activation.

Int J Cancer , 2006. 118 (10): pp. 2448-2454.

136. He, Y., ., The role of c-myc in regulating mdr1 gene expression in

tumor cell line KB.

et al

Chin Med J ( Engl ), 2000. 113 (9): pp. 848-851.

137. Banerjee, S., ., Down-regulation of ras and myc expression

associated with mdr-1 overexpression in adriamycin-resistant tumor
cells.

et al

(6): pp. 561-570.
138. Duceppe, N., and M. Tabrizian, Factors influencing the transfection
efficiency of ultra low molecular weight chitosan/hyaluronic acid
nanoparticles.

Cell Mol Biol , 1992. 38

Biomaterials , 2009. 30 (13): pp. 2625-2631.

139. Chono, S., ., An efficient and low immunostimulatory nanoparticle

formulation for systemic siRNA delivery to the tumor.

et al

J Control Release ,

(1): pp. 64-69.
140. Schwartz, D.A.,

2008. 131

., CpG motifs in bacterial DNA cause inflammation
in the lower respiratory tract.

et al

J Clin Invest , 1997. 100 (1): pp. 68-73.

141. Lapcik, L., Jr., et al ., Hyaluronan: preparation, structure, properties, and

(8): pp. 2663-2684.
142. Toole, B.P., Hyaluronan: from extracellular glue to pericellular cue.
Nat Rev Cancer

applications. Chem Rev , 1998. 98

(7): pp. 528-539.
143. Eliaz, R.E., and F.C. Szoka, Jr., Liposome-encapsulated doxorubicin
targeted to CD44: a strategy to kill CD44-overexpressing tumor cells.
Cancer Res

, 2004. 4

(6): pp. 2592-2601.
144. Platt, V.M., and F.C. Szoka, Jr., Anticancer therapeutics: targeting
macromolecules and nanocarriers to hyaluronan or CD44, a hyaluronan
receptor.

, 2001. 61

(4): pp. 474-486.
145. Uskokovic, V., and D.P. Uskokovic, Nanosized hydroxyapatite and
other calcium phosphates: chemistry of formation and application as
drug and gene delivery agents.

Mol Pharm , 2008. 5

J Biomed Mater Res B Appl Biomater ,

(1): pp. 152-191.
146. Auzenne, E.,

2011. 96

., Hyaluronic acid-paclitaxel: antitumor efficacy
against CD44(+) human ovarian carcinoma xenografts.

et al

Neoplasia ,

2007. 9 (6): pp. 479-486.

147. Li, J., ., Biodegradable calcium phosphate nanoparticle with lipid

coating for systemic siRNA delivery.

et al

J Control Release , 2010. 142 (3):

pp. 416-421.
148. Kester, M., et al ., Calcium phosphate nanocomposite particles for in

vitro imaging and encapsulated chemotherapeutic drug delivery to

cancer cells.

Nano Lett , 2008. 8 (12): pp. 4116-4121.